Vnitr Lek 2012, 58(5):390-392

Vitamin D in aortic stenosis

K. Linhartová1,*, G. Štěrbáková2, R. Čerbák3
1 Kardiologická klinika 2. lékařské fakulty UK a FN Motol Praha, přednosta prof. MUDr. Josef Veselka, CSc.
2 I. interní klinika Lékařské fakulty UK a FN Plzeň, přednosta prof. MUDr. Martin Matějovič, Ph.D.
3 Centrum kardiovaskulární a transplantační chirurgie Brno, ředitel doc. MUDr. Petr Němec, CSc.

Aortic stenosis is the third most common cardiovascular disease and the most commonly operataed valve disease in developed countries. Progressive valve calcification leading to significant flow obstruction is the main pathogenetic feature. Dysregulation of the systemic calcium-phosphate metabolism with low vitamin D level is a possible risk factor of aortic stenosis even in patients with preserved renal function. This hypothesis deserves further clinical and experimental study.

Keywords: calcification of the aortic valve; vitamin D; aortic stenosis

Received: September 30, 2011; Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Linhartová K, Štěrbáková G, Čerbák R. Vitamin D in aortic stenosis. Vnitr Lek. 2012;58(5):390-392.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29: 630-634. Go to original source... Go to PubMed...
    2. Faggiano P, Antonini-Canterin F, Ehrlicher A et al. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol 2003; 91: 99-101. Go to original source... Go to PubMed...
    3. Otto CM, Kuusisto I, Reichenbach DD et al. Characterization of the early lesion in "degenerative valvular aortic stenosis": histological and immunohistochemical studies. Circulation 1994; 90: 844-853. Go to original source... Go to PubMed...
    4. Linhartová K, Čerbák R, Rosolová H. Aortální stenóza, skleróza a ateroskleróza. Vnitř Lék 2005; 51: 458-461.
    5. Cowell SJ, Newby DE, Prescott RJ et al. Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 2389-2397. Go to original source... Go to PubMed...
    6. Rossebø AB, Pedersen TR, Skjaerpe T et al. Design of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study. Am J Cardiol 2007; 99: 970-973. Go to original source... Go to PubMed...
    7. Chan KL, Teo K, Dumesnil JG et al. ASTRONOMER Investigators. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010; 121: 306-314. Go to original source... Go to PubMed...
    8. Persy V, D'Haese P. Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 2009; 15: 405-416. Go to original source... Go to PubMed...
    9. Rajamannan NM, Subramaniam M, Rickard D et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003; 107: 2181-2184. Go to original source... Go to PubMed...
    10. Mohler ER 3rd, Gannon F, Reynolds C et al. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522-1528. Go to original source... Go to PubMed...
    11. Ortlepp JR, Hoffmann R, Ohme F et al. The vitamin D receptor genotype predisposes to the development of calcific aortic stenosis. Heart 2001; 85: 635-638. Go to original source... Go to PubMed...
    12. Schmitz F, Ewering S, Zerres K et al. Parathyroid hormone gene variant and calcific aortic stenosis. J Heart Valve Dis 2009; 18: 262-267. Go to PubMed...
    13. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701. Go to original source... Go to PubMed...
    14. Kume T, Kawamoto T, Akasaka T et al. Rate of progression of valvular aortic stenosis in pa-tients undergoing dialysis. J Am Soc Echocardiogr 2006; 19: 914-918. Go to original source... Go to PubMed...
    15. Qunibi WY, Nolan CA, Ayus JC. Cardiovascular calcification in patients with end-stage renal disease: a century old phenomenon. Kidney International 2002; 62 (Suppl 82): S73-S80. Go to original source... Go to PubMed...
    16. Linefsky JP, O'Brien KD, Katz R et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. J Am Coll Cardiol 2011; 58: 291-297. Go to original source... Go to PubMed...
    17. Linhartova K, Veselka J, Sterbakova G et al. Parathyroid hormone and Vitamin D levels are independently associated with calcific aortic stenosis Circ J 2008; 78: 245-250. Go to original source... Go to PubMed...
    18. Pal BR, Marshall T, James C et al. Distribution analysis of vitamin D highlights differences in population subgroups: preliminary observations from a pilot study in UK adults. J Endocrinol 2003; 179: 119-129. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.